Serveur d'exploration Stress et Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Toxoplasma gondii and other risk factors for schizophrenia: an update.

Identifieur interne : 001281 ( Main/Exploration ); précédent : 001280; suivant : 001282

Toxoplasma gondii and other risk factors for schizophrenia: an update.

Auteurs : E Fuller Torrey [États-Unis] ; John J. Bartko ; Robert H. Yolken

Source :

RBID : pubmed:22446566

Descripteurs français

English descriptors

Abstract

The failure to find genes of major effect in schizophrenia has refocused attention on nongenetic, including infectious factors. In a previous study, antibodies to Toxoplasma gondii were found to be elevated in 23 studies of schizophrenia (OR 2.73; 95% CI 2.10-3.60). The current study replicates this finding with 15 additional studies (OR 2.71; 95% CI 1.93-3.80) and compares this with other identified schizophrenia risk factors. The highest risk factors are having an affected mother (relative risks [RR] 9.31; 95% CI 7.24-11.96), father (RR 7.20; 95% CI 5.10-10.16), or sibling (RR 6.99; 95% CI 5.38-9.08) or being the offspring of immigrants from selected countries (RR 4.5; 95% CI 1.5-13.1). Intermediate risk factors, in addition to infection with T. gondii, include being an immigrant from and to selected countries (RR 2.7; 95% CI 2.3-3.2), being born in (RR 2.24; 95% CI 1.92-2.61) or raised in (RR 2.75; 95% CI 2.31-3.28) an urban area, cannabis use (OR 2.10-2.93; 95% CI 1.08-6.13), having minor physical anomalies (OR 2.23; 95% CI 1.42-3.58), or having a father 55 or older (OR 2.21-5.92; 95% CI 1.46-17.02). Low-risk factors include a history of traumatic brain injury (OR 1.65; 95% CI 1.17-2.32), sex abuse in childhood (OR 1.46; 95% CI 0.84-2.52), obstetrical complications (OR 1.29-1.38; 95% CI 1.00-1.84), having a father 45 or older (OR 1.21-1.66; 95% CI 1.09-2.01), specific genetic polymorphisms (OR 1.09-1.24; 95% CI 1.06-1.45), birth seasonality (OR 1.07-1.95; 95% CI 1.05-2.91), maternal exposure to influenza (RR 1.05; 95% CI 0.98-1.12), or prenatal stress (RR 0.98-1.00; 95% CI 0.85-1.16).

DOI: 10.1093/schbul/sbs043
PubMed: 22446566


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Toxoplasma gondii and other risk factors for schizophrenia: an update.</title>
<author>
<name sortKey="Torrey, E Fuller" sort="Torrey, E Fuller" uniqKey="Torrey E" first="E Fuller" last="Torrey">E Fuller Torrey</name>
<affiliation wicri:level="2">
<nlm:affiliation>The Stanley Medical Research Institute, 8401 Connecticut Avenue, Suite 200, Chevy Chase, MD 20815, USA. torreyf@stanleyresearch.org</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Stanley Medical Research Institute, 8401 Connecticut Avenue, Suite 200, Chevy Chase, MD 20815</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bartko, John J" sort="Bartko, John J" uniqKey="Bartko J" first="John J" last="Bartko">John J. Bartko</name>
</author>
<author>
<name sortKey="Yolken, Robert H" sort="Yolken, Robert H" uniqKey="Yolken R" first="Robert H" last="Yolken">Robert H. Yolken</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22446566</idno>
<idno type="pmid">22446566</idno>
<idno type="doi">10.1093/schbul/sbs043</idno>
<idno type="wicri:Area/PubMed/Corpus">000578</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000578</idno>
<idno type="wicri:Area/PubMed/Curation">000576</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000576</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000544</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000544</idno>
<idno type="wicri:Area/Ncbi/Merge">000513</idno>
<idno type="wicri:Area/Ncbi/Curation">000513</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000513</idno>
<idno type="wicri:Area/Main/Merge">001283</idno>
<idno type="wicri:Area/Main/Curation">001281</idno>
<idno type="wicri:Area/Main/Exploration">001281</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Toxoplasma gondii and other risk factors for schizophrenia: an update.</title>
<author>
<name sortKey="Torrey, E Fuller" sort="Torrey, E Fuller" uniqKey="Torrey E" first="E Fuller" last="Torrey">E Fuller Torrey</name>
<affiliation wicri:level="2">
<nlm:affiliation>The Stanley Medical Research Institute, 8401 Connecticut Avenue, Suite 200, Chevy Chase, MD 20815, USA. torreyf@stanleyresearch.org</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Stanley Medical Research Institute, 8401 Connecticut Avenue, Suite 200, Chevy Chase, MD 20815</wicri:regionArea>
<placeName>
<region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bartko, John J" sort="Bartko, John J" uniqKey="Bartko J" first="John J" last="Bartko">John J. Bartko</name>
</author>
<author>
<name sortKey="Yolken, Robert H" sort="Yolken, Robert H" uniqKey="Yolken R" first="Robert H" last="Yolken">Robert H. Yolken</name>
</author>
</analytic>
<series>
<title level="j">Schizophrenia bulletin</title>
<idno type="eISSN">1745-1701</idno>
<imprint>
<date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antibodies, Protozoan (biosynthesis)</term>
<term>Humans</term>
<term>Risk Factors</term>
<term>Schizophrenia (etiology)</term>
<term>Schizophrenia (genetics)</term>
<term>Schizophrenia (parasitology)</term>
<term>Toxoplasma (immunology)</term>
<term>Toxoplasma (pathogenicity)</term>
<term>Toxoplasmosis (complications)</term>
<term>Toxoplasmosis (genetics)</term>
<term>Toxoplasmosis (psychology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Anticorps antiprotozoaires (biosynthèse)</term>
<term>Facteurs de risque</term>
<term>Humains</term>
<term>Schizophrénie (génétique)</term>
<term>Schizophrénie (parasitologie)</term>
<term>Schizophrénie (étiologie)</term>
<term>Toxoplasma (immunologie)</term>
<term>Toxoplasma (pathogénicité)</term>
<term>Toxoplasmose ()</term>
<term>Toxoplasmose (génétique)</term>
<term>Toxoplasmose (psychologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en">
<term>Antibodies, Protozoan</term>
</keywords>
<keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr">
<term>Anticorps antiprotozoaires</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Toxoplasmosis</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Schizophrenia</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Schizophrenia</term>
<term>Toxoplasmosis</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Schizophrénie</term>
<term>Toxoplasmose</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Toxoplasma</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Toxoplasma</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr">
<term>Schizophrénie</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitology" xml:lang="en">
<term>Schizophrenia</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en">
<term>Toxoplasma</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr">
<term>Toxoplasma</term>
</keywords>
<keywords scheme="MESH" qualifier="psychologie" xml:lang="fr">
<term>Toxoplasmose</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en">
<term>Toxoplasmosis</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Schizophrénie</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Facteurs de risque</term>
<term>Humains</term>
<term>Toxoplasmose</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The failure to find genes of major effect in schizophrenia has refocused attention on nongenetic, including infectious factors. In a previous study, antibodies to Toxoplasma gondii were found to be elevated in 23 studies of schizophrenia (OR 2.73; 95% CI 2.10-3.60). The current study replicates this finding with 15 additional studies (OR 2.71; 95% CI 1.93-3.80) and compares this with other identified schizophrenia risk factors. The highest risk factors are having an affected mother (relative risks [RR] 9.31; 95% CI 7.24-11.96), father (RR 7.20; 95% CI 5.10-10.16), or sibling (RR 6.99; 95% CI 5.38-9.08) or being the offspring of immigrants from selected countries (RR 4.5; 95% CI 1.5-13.1). Intermediate risk factors, in addition to infection with T. gondii, include being an immigrant from and to selected countries (RR 2.7; 95% CI 2.3-3.2), being born in (RR 2.24; 95% CI 1.92-2.61) or raised in (RR 2.75; 95% CI 2.31-3.28) an urban area, cannabis use (OR 2.10-2.93; 95% CI 1.08-6.13), having minor physical anomalies (OR 2.23; 95% CI 1.42-3.58), or having a father 55 or older (OR 2.21-5.92; 95% CI 1.46-17.02). Low-risk factors include a history of traumatic brain injury (OR 1.65; 95% CI 1.17-2.32), sex abuse in childhood (OR 1.46; 95% CI 0.84-2.52), obstetrical complications (OR 1.29-1.38; 95% CI 1.00-1.84), having a father 45 or older (OR 1.21-1.66; 95% CI 1.09-2.01), specific genetic polymorphisms (OR 1.09-1.24; 95% CI 1.06-1.45), birth seasonality (OR 1.07-1.95; 95% CI 1.05-2.91), maternal exposure to influenza (RR 1.05; 95% CI 0.98-1.12), or prenatal stress (RR 0.98-1.00; 95% CI 0.85-1.16).</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Maryland</li>
</region>
</list>
<tree>
<noCountry>
<name sortKey="Bartko, John J" sort="Bartko, John J" uniqKey="Bartko J" first="John J" last="Bartko">John J. Bartko</name>
<name sortKey="Yolken, Robert H" sort="Yolken, Robert H" uniqKey="Yolken R" first="Robert H" last="Yolken">Robert H. Yolken</name>
</noCountry>
<country name="États-Unis">
<region name="Maryland">
<name sortKey="Torrey, E Fuller" sort="Torrey, E Fuller" uniqKey="Torrey E" first="E Fuller" last="Torrey">E Fuller Torrey</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001281 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001281 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:22446566
   |texte=   Toxoplasma gondii and other risk factors for schizophrenia: an update.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:22446566" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a StressCovidV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021